Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population PK/PD of propofol and nadroparin in extremely morbidly obese surgical patients
NL-OMON36134Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Feb 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of propofol and nadroparin in obesity, sponsored by St. Antonius Ziekenhuis. Primary endpoints: Propofol pharmacokinetic parameters and Nadroparin pharmacodynamic/pharmacokinetic model parameters using anti-Xa. Started Feb 2012; status: active, not recruiting.
02
Drugs
propofolnadroparin
03
Conditions
obesity
Beyond the preview
Go deeper on NL-OMON36134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36134.